Skip to main content

Clinical Trials in Pakistan: Opportunities and Challenges

Buy Article:

$68.00 + tax (Refund Policy)

Pakistan is a developing country bordering India and China. It is the seventh most populous country in the world. Though there is a large treatment naive population, high disease burden, well established and internationally recognized, Good Clinical Practice compliant health care institutions, internationally trained, English speaking researchers, yet Pakistan has not made its mark in the global clinical trials market. Even though Clinical trials have been going on for well over a decade in the country, the activities have been fragmented and efforts will need to be made to streamline the national infrastructure. The manuscript discusses the challenges and opportunities to conduct clinical trials in Pakistan.

Keywords: Clinical trials; Pakistan; academic; challenges; disease burden; health infrastructure; opportunities; potential market; regulatory; research

Document Type: Research Article

Publication date: 01 April 2014

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content